Cargando…
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
Autores principales: | Deng, Qingfu, Luo, Li, Quan, Zhen, Liu, Nanjing, Du, Zhongbo, Sun, Wei, Luo, Chunli, Wu, Xiaohou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178667/ https://www.ncbi.nlm.nih.gov/pubmed/35616141 http://dx.doi.org/10.3892/mmr.2022.12746 |
Ejemplares similares
-
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
por: Deng, Qingfu, et al.
Publicado: (2019) -
Functional significance of the hepaCAM gene in bladder cancer
por: He, Yunfeng, et al.
Publicado: (2010) -
Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM
por: Li, Ting, et al.
Publicado: (2020) -
HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
por: Du, Zhongbo, et al.
Publicado: (2018) -
HepaCAM-PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation
por: He, Zhenting, et al.
Publicado: (2022)